Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01568008 · clinicaltrials.gov ↗

COMPLETED

Status

933

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Bimatoprost 0.01% ophthalmic solution

Sponsor

Allergan